AGC Biologics will commence cell therapy process development and clinical manufacturing services on July 1 at AGC Inc.’s ...

Cellular Origins has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform ...

OXB completes acquisition of remaining stake in US subsidiary Progression to full ownership aligns with global strategy and ...

Cancer cells can acquire energy-generating structures called mitochondria from nearby nerve cells, which seems to aid their ...

Although progress was initially slower than anticipated, scientific breakthroughs in the past 10 years have accelerated advances in gene therapy, also known as gene transfer or gene replacement. Gene ...

New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential Press ReleaseCarmil Therapeutics to develop next-generation immunotherapies ...

The US subsidiary will focus on advancing PolTreg's pipeline, including its lead candidate PTG-007 in type 1 diabetes, in these new territories.

People living with Sickle Cell Disease (SCD) in Nigeria have lamented that the high cost of medication and poor access to comprehensive care are weighing heavily on them and their families.

(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to a session on non-beta emitter PSMA radioligand therapy. Dr.

MIAMI, FL / ACCESS Newswire / June 25, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage privately-held ...

To no great surprise, the U.K.’s health technology assessment body has found that the benefits of the first two approved Alzheimer’s disease drugs are too small to justify the costs. Neither Kisunla ...